
Twist is looking for a customer facing bioinformatics professional to serve as a technical application scientist for Twist’s customers and to be an integral part of our Sales team. This role will function as a liaison between the customer and Twist to help customers understand the scientific and technical challenges they are facing and how these may be solved through deployment of our custom NGS panels. In this capacity he/she will be responsible for the pre- and post-sales support and market development activities for Twist’s NGS target enrichment portfolio. Prior experience with Next Generation Sequencing and target enrichment will be essential to enable translation of customer requirements to internal teams. This position can be remote, with travel requirements of up to 10%.
What You’ll Be Doing
What You’ll Bring to the Team
Preferred Qualifications
Twist Bioscience synthesizes genes from scratch, known as “writing” DNA. Just as children learn to both read and write, the next phase of development for the genomics revolution is the ability to write DNA.
At Twist Bioscience, we work in service of people who are changing the world for the better. In fields such as health care, agriculture, industrial chemicals and data storage, our unique silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers.
Twist Bioscience Corporation is an Equal Opportunity Employer. Twist Bioscience Corporation provides equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, genetic characteristics, or any other category protected by law.
From job listings to startups, investors to funding rounds, and everything in between, Employbl puts the power in your hands. Why wait?
Start your free trial today!Sign up for our newsletter to stay informed about the latest startups and trends in the tech market. Let Employbl be your guide to success.
Between 923 - 923 employees
2013
$553,110,720
Post Ipo Equity
$250,000,000 USD
Post Ipo Equity
$50,000,000 USD
Series Unknown
$50,000,000 USD
IPO
$0
Series Unknown
$27,000,000 USD
Series Unknown
$33,000,000 USD
Series D
$61,000,000 USD
Series C
$37,000,000 USD
Debt Financing
$10,000,000 USD
Series B
$26,000,000 USD
Series A
$9,110,714 USD